These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30235055)

  • 1. Intraosseous Administration of Tissue Plasminogen Activator on a Mobile Stroke Unit.
    Bowry R; Nour M; Kus T; Parker S; Stephenson J; Saver J; Grotta JC; Ostermayer D
    Prehosp Emerg Care; 2019; 23(4):447-452. PubMed ID: 30235055
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of Stroke Treatment Using a Mobile Stroke Unit Compared With Standard Management: The BEST-MSU Study Run-In Phase.
    Bowry R; Parker S; Rajan SS; Yamal JM; Wu TC; Richardson L; Noser E; Persse D; Jackson K; Grotta JC
    Stroke; 2015 Dec; 46(12):3370-4. PubMed ID: 26508753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced dispatch and rendezvous doubles the catchment area and number of patients treated on a mobile stroke unit.
    Parker SA; Kus T; Bowry R; Gutierrez N; Cai C; Yamal JM; Rajan S; Wang M; Jacob AP; Souders C; Persse D; Grotta JC
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104894. PubMed ID: 32689599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing Emergency Neurology to Ambulances: Mobile Stroke Unit.
    Bowry R; Grotta JC
    Semin Respir Crit Care Med; 2017 Dec; 38(6):713-717. PubMed ID: 29262428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Study of Adverse Events After Intravenous Tissue-Type Plasminogen Activator Treatment of Acute Ischemic Stroke.
    Fernandez-Gotico H; Lightfoot T; Meighan M
    J Neurosci Nurs; 2017 Feb; 49(1):31-36. PubMed ID: 28060219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mobile CT: technical aspects of prehospital stroke imaging before intravenous thrombolysis].
    Gierhake D; Weber JE; Villringer K; Ebinger M; Audebert HJ; Fiebach JB
    Rofo; 2013 Jan; 185(1):55-9. PubMed ID: 23059698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of thrombolytic therapy after stroke-bypass transportation: the Maria Prehospital Stroke Scale score.
    Hasegawa Y; Sasaki N; Yamada K; Ono H; Kumai J; Tsumura K; Suzuki K; Nozaki H; Nakayama H; Takumi I; Nikaido H; Katabami T; Ueda T; Suzuki S; Iwai R; Takahashi H; Shigeno T
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):514-9. PubMed ID: 23489953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prehospital triage to primary stroke centers and rate of stroke thrombolysis.
    Prabhakaran S; O'Neill K; Stein-Spencer L; Walter J; Alberts MJ
    JAMA Neurol; 2013 Sep; 70(9):1126-32. PubMed ID: 23817961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to Decision and Treatment With tPA (Tissue-Type Plasminogen Activator) Using Telemedicine Versus an Onboard Neurologist on a Mobile Stroke Unit.
    Bowry R; Parker SA; Yamal JM; Hwang H; Appana S; Rangel-Gutierrez N; Wu TC; Rajan SS; Grotta JC
    Stroke; 2018 Jun; 49(6):1528-1530. PubMed ID: 29720439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute ischemic stroke: comparison of low-dose and standard-dose regimes of tissue plasminogen activator.
    Sharma VK; Kawnayn G; Sarkar N
    Expert Rev Neurother; 2013 Aug; 13(8):895-902. PubMed ID: 23965163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME; Nunziato EC; Labovitz DL
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):808-11. PubMed ID: 21640608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.
    Lewandowski CA; Frankel M; Tomsick TA; Broderick J; Frey J; Clark W; Starkman S; Grotta J; Spilker J; Khoury J; Brott T
    Stroke; 1999 Dec; 30(12):2598-605. PubMed ID: 10582984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.